相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer
Kazuya Takamochi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer
Tsuneo Shimokawa et al.
CANCER MEDICINE (2021)
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone et al.
NATURE MEDICINE (2021)
Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin plus pemetrexed for locally advanced non-squamous non small cell lung cancer: SPECTRA study
Seiji Niho et al.
LUNG CANCER (2020)
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
Catherine A. Shu et al.
LANCET ONCOLOGY (2020)
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Mariano Provencio et al.
LANCET ONCOLOGY (2020)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L
Tomonari Sasaki et al.
BRITISH JOURNAL OF CANCER (2018)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Nasser Hanna et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer
Masafumi Yamaguchi et al.
ANNALS OF THORACIC SURGERY (2013)
S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)
Yukito Ichinose et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo
Masakazu Fukushima et al.
ONCOLOGY REPORTS (2010)
Gimeracil sensitizes cells to radiation via inhibition of homologous recombination
Masaru Takagi et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
F. Ohyanagi et al.
BRITISH JOURNAL OF CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
P Zatloukal et al.
LUNG CANCER (2004)
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and leukemia group B study 9431
EE Vokes et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
